Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New five-year plan against AMR announced
The next five-year plan will run from 2024 to 2029.
It forms part of the government’s plans to control AMR by 2040.

The Department of Health and Social Care has launched the second stage of its five-year plan, as it seeks to control antimicrobial resistance (AMR) by 2040.

The latest National Action Plan (NAP) seeks to build upon work completed as part of the previous five-year plan, and sets new ambitious targets for reducing antibiotic use.

New commitments will see the UK, including the veterinary sector, challenged to reduce its usage of antimicrobials in humans and animals. It also calls for tighter surveillance of drug resistant infections, and more incentive for industries to develop new treatments.

The five-year plan, which will run from 2024 to 2029, covers nine strategic outcomes organised into four themes.

Firstly, the NAP intends to reduce the necessity of, and unintentional exposure to, antimicrobials. To achieve this, work will focus on preventing infections, monitoring their emergence and spread, and minimising their release into the environment.

The efficacy of existing microbials will be protected by optimising their use, ensuring that they are only used when needed.

Innovation, supply and access is set to be encouraged, as the government seeks to find new vaccines, diagnostics and therapeutics. Manufacturers will be incentivised to make them accessible to those who need them, and to ensure their work is founded in AMR research.

Finally the UK will look to remain an international leader in AMR, supporting low- and middle-income countries as they also challenge AMR.

Christine Middlemiss, the UK’s chief veterinary officer, said: “The UK has made fantastic progress in the past 10 years to reduce AMR in animals, working between government, farming industry, vets, and animal keepers to reduce the use of antibiotics in food-producing animals by more than half.
 
“The new National Action Plan will build upon these achievements, and I urge vets and animal keepers to continue to support the UK’s 20-year vision to contain and control AMR.”

The Responsible use of Medicines in Agriculture (RUMA) Alliance has also welcomed the next stage of the plan.

RUMA chair Cat McLaughlin said: “RUMA is very pleased to see the launch of the second five-year National Action Plan today which further supports and drives UK efforts to tackle AMR from a One Health perspective.

“In the UK, the responsible use of medicines across UK farming is already part of everyday language, with farmers and vets working collaboratively to embed best practice for responsible use and reductions across all sectors.”

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Vetlife nominated for campaign award

News Story 1
 Vetlife has been shortlisted for the Association of Charity Organisations (ACO) Campaign of the Year Award 2024.

The nomination recognises its campaigning to raise awareness of neurodiversity within the profession and produce resources for individuals and workplaces. Vetlife's campaign has included talks, lived experience blogs, and an awareness video.

Kirstie Pickles, Vetlife trustee and project lead, said: "I am thrilled and delighted that the Vetlife neurodiversity awareness campaign has been shortlisted for the ACO Campaign of the Year Award 2024"

The winner will be announced 12 September 2024. 

Click here for more...
News Shorts
Northern Ireland chief vet warns of bluetongue risk

Following the detection of bluetongue virus serotype 3 (BTV-3) in England, Northern Ireland's chief veterinary officer has urged farmers to remain vigilant and source animals responsibly.

Brian Dooher said: "This confirmation in England is a stark reminder of the threat bluetongue presents to Northern Ireland.Whilst this finding in Norfolk is disappointing it is not unexpected giving the rising level of disease across several countries in Europe. Bluetongue does not affect human health or food safety, however an incursion to Northern Ireland would have a significant impact on livestock and the rural economy.

"I would like to remind all farmers of the importance of sourcing animals responsibly and ask that they maintain vigilance for signs of the disease reporting any suspicions to DAERA immediately."

Suspected cases of BTV-3 in Northern Ireland should be reported to the DAERA Helpline on 0300 200 7840 or by contacting the local DAERA Direct Veterinary Office.